In summary, our findings demonstrate that the biotechnologically produced LV extract diminished psoriasis-like inflammation in human keratinocytes by interfering the JAK2/STAT1 signaling and its effectiveness is due to the high content of RA. The gene discussed is JAK2; the disease is psoriasis.